Şunu aradınız:: meningococcal (İngilizce - Slovence)

meningococcal infection
meningokokna okužba

meningococcal disease(10)
meningokokne bolezni *

protection against meningococcal disease
zaščita pred meningokokno boleznijo

meningococcal group a oligosaccharide 10 micrograms
oligosaharid meningokoka skupine a 10 mikrogramov

bexsero is a meningococcal group b vaccine.
cepivo bexsero je cepivo proti meningokokom skupine b.

the most serious side effect was meningococcal sepsis.
najresnejši neželeni učinek je bila meningokokna sepsa.

meningococcal group w135 oligosaccharides 5 micrograms conjugated to
oligosaharidi meningokoka skupine w135, 5 mikrogramov, vezani na beljakovino crm197 bakterije

meningococcal group a, c, w135 and y conjugate vaccine
konjugirano cepivo proti meningokokom skupin a, c, w135 in y

vaccination may not be sufficient to prevent meningococcal infection.
cepljenje morda ne bo zadostovalo za preprečevanje meningokokne okužbe.

pharmacotherapeutic group: meningococcal vaccines, atc code: j07ah08.
farmakoterapevtska skupina: cepiva proti meningokokom, oznaka atc: j07ah08.

effect of prior vaccination with plain polysaccharide meningococcal vaccine
vpliv predhodnega cepljenja z navadnim polisaharidnim meningokoknim cepivom

patients received meningococcal vaccination prior to receipt of soliris.
pred pričetkom jemanja zdravila soliris so bili bolniki cepljeni proti meningokokom.

bexsero meningococcal group b vaccine (rdna, component, adsorbed)
bexsero cepivo proti meningokokom skupine b (rekombinantno, komponentno, adsorbirano)

if available, tetravalent, conjugated vaccines are recommended (see meningococcal disease).
Če so na voljo, so priporočljiva štirivalentna konjugirana cepiva (glejte meningokokna bolezen).

cases of serious or fatal meningococcal infections have been reported in soliris-treated patients.
pri bolnikih, ki so bili zdravljeni z zdravilom soliris, so poročali o primerih meningokokne okužbe z resnim ali s smrtnim izidom.

there was an un-vaccinated patient diagnosed with idiopathic membranous glomerulonephropathy who experienced meningococcal meningitis.
pri enem necepljenem bolniku, pri katerem je bila diagnosticirana idiopatska membranska glomerulonefropatija, se je pojavil meningokokni meningitis.

haemophilus influenzae type b polysaccharide (polyribosylribitol phosphate) 3 micrograms conjugated to meningococcal protein2 50 micrograms
konjugiran na meningokokno beljakovino2 50 mikrogramov

haemophilus b conjugate (meningococcal protein conjugate) and hepatitis b (recombinant) vaccine.
procomvax suspenzija za injiciranje v viali konjugirano cepivo proti hemofilusu b (meningokokni beljakovinski konjugat) in rekombinantno cepivo proti hepatitisu b

although group b meningococcal disease is relatively uncommon in europe, the chmp noted that it is more common in certain regions of europe.
Čeprav je meningokokna bolezen skupine b v evropi sorazmerno redka, je opozoril, da je v določenih evropskih regijah pogostejša.

drug distribution will only be possible after written confirmation that the patient has effectively received meningococcal vaccination and/or antibiotic prophylaxis.
bo distribucija zdravila možna samo po pisnem zagotovilu, da je bilo pri bolniku izvedeno učinkovito cepljenje proti meningokoku in/ali je prejel ustrezno antibiotično profilakso;